Crystal Structure of HIV-1 Reverse Transcriptase in Complex with (E)-3-(3-chloro-5-(4-chloro-2-(2-(2,4-dioxo-3,4- dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (JLJ494), a Non-nucleoside Inhibitor

Citations in PubMed

Primary Citation PubMed: 23163887 Citations in PubMed

PDB ID Mentions in PubMed Central Article count: 1

Citations in PubMed

This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.

PDB ID Mentions in PubMed Central

Data mentions are occurrences of PDB IDs in the full text articles from the PubMedCentral Open Access Subset of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed. Article titles can be filtered by keywords and sorted by year.

  • 3 per page
  • 5 per page
  • 10 per page
  • view all
  • Publication Year
  • Ascending
  • Descending

PubMed ID is not available.

Published in 2015

PubMedCentral: PMC4378236

Table 1 Antiviral Activity and Solubility Data for Compounds 1 - 3 and FDA-Approved NNRTIs compd WT EC 50 (nM) Y181C EC 50 (nM) K103N/Y181C EC 50 (nM) solubility (μg/mL) 1 0.055 49 220 NA 2 0.... 1 46 24 510 3 0.32 16 85 10.8 rilpivirine 0.67 0.65 2 0.02–0.24 nevirapine 110 NA NA 167 efavirenz 2 10 30 68 General Structure Details for RT (WT), RT (Y181C), and RT (K103N/Y181C) To elucidate the effects of K103N and Y181C mutations on inhibitor binding, we determined crystal structures of RT (Y181C) and RT (K103N/Y181C) in complex with compound 1 to compare with the previously determined RT (WT): 1 crystal structure (PDB code: 4H4M).

Publication Year: 2015